Chimerix Inc. (CMRX)

2.44
NASDAQ : Health Technology
Prev Close 2.34
Day Low/High 2.33 / 2.47
52 Wk Low/High 1.74 / 4.40
Avg Volume 370.90K
Exchange NASDAQ
Shares Outstanding 61.27M
Market Cap 143.37M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
First Week of CMRX August 21st Options Trading

First Week of CMRX August 21st Options Trading

Investors in Chimerix Inc. saw new options begin trading this week, for the August 21st expiration.

Chimerix Provides Recap Of 2014 Events

Chimerix Provides Recap Of 2014 Events

New Lifetime High Reached By Chimerix (CMRX)

New Lifetime High Reached By Chimerix (CMRX)

Trade-Ideas LLC identified Chimerix (CMRX) as a new lifetime high candidate

Chimerix And ContraVir Pharmaceuticals Establish Strategic Collaboration For Antiviral Drug Candidate CMX157

Chimerix And ContraVir Pharmaceuticals Establish Strategic Collaboration For Antiviral Drug Candidate CMX157

ContraVir to Develop CMX157 for Multiple Antiviral Indications

CMRX: Insiders vs. Shorts

CMRX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 11/28/2014 settlement date, and Chimerix Inc. is one of the most shorted stocks of the Russell 3000, based on 8.02 "days to cover" versus the median component at 6.85.

Today's Dead Cat Bounce Stock: Chimerix (CMRX)

Today's Dead Cat Bounce Stock: Chimerix (CMRX)

Trade-Ideas LLC identified Chimerix (CMRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

January 2016 Options Now Available For Chimerix (CMRX)

January 2016 Options Now Available For Chimerix (CMRX)

Investors in Chimerix Inc. saw new options become available today, for the January 2016 expiration.

Chimerix Announces Third Quarter 2014 Financial Results

Chimerix Announces Third Quarter 2014 Financial Results

Management to Hold Conference Call Today at 8:30am ET

First Week of December 20th Options Trading For Chimerix (CMRX)

First Week of December 20th Options Trading For Chimerix (CMRX)

Investors in Chimerix Inc. saw new options become available this week, for the December 20th expiration.

Chimerix (CMRX) Down In After-Hours Trading

Chimerix (CMRX) Down In After-Hours Trading

Trade-Ideas LLC identified Chimerix (CMRX) as a post-market laggard candidate

Chimerix Gets FDA OK to Test Experimental Drug For Ebola

Chimerix Gets FDA OK to Test Experimental Drug For Ebola

A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Chimerix Gets FDA OK to Test Experimental Drug for Ebola

Chimerix Gets FDA OK to Test Experimental Drug for Ebola

A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback

Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback

Here are four biotechs to consider, two of which are involved in developing drugs to fight the Ebola virus.

Chimerix (CMRX) Showing Signs Of Perilous Reversal Today

Chimerix (CMRX) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Chimerix (CMRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Chimerix (CMRX) Hits New Lifetime High Today

Chimerix (CMRX) Hits New Lifetime High Today

Trade-Ideas LLC identified Chimerix (CMRX) as a new lifetime high candidate

Chimerix Provides Update On Research And Development Progress

Chimerix Provides Update On Research And Development Progress

Highlights Advancement of Second Clinical Candidate, CMX16669, for CMV and BK Virus

Trade-Ideas: Chimerix (CMRX) Is Today's Post-Market Leader Stock

Trade-Ideas: Chimerix (CMRX) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Chimerix (CMRX) as a post-market leader candidate

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Ebola Linked Names Rise Again Amid Broader Market Sell-Off

Shares of companies leveraged to Ebola are rising again after a second health care worker in the U.S. tested positive for the illness.

'Fast Money' Recap: How to Trade in a Volatile Marketplace

'Fast Money' Recap: How to Trade in a Volatile Marketplace

The trading panel discussed defensive trades, the state of the market and whether Carl Icahn is right about Apple.

Lakeland Industries Continues To Surge Amid Ebola Fears

Lakeland Industries Continues To Surge Amid Ebola Fears

Shares of Lakeland Industries, which supplies protective clothing to the Centers for Disease Control and other governmental agencies, are soaring amid continued fears over the Ebola outbreak...

TheStreet Quant Rating: D (Sell)